Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

sounds like LymPro

4. "We are aware that it is possible in the biotechnology industry to gain strong financial terms from potential partners eager to gain access to the Company’s technology – we can now aggressively pursue this strategy without the risk of a significant dilutive financing throughout that process"

sounds like NASDAQ up-listing

2. "Between today and the next time the Company would need cash, we have a number of fundamental value-building milestones that we believe will shift the investment thesis underpinning Amarantus, thereby allowing these milestones to get priced into the market ahead of drawing down on additional capital"

http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/transformational-funding-positions-amarantus-heading-2014-milestones/#sthash.cXizqIHP.dpuf